NOVEL Act of 2021
USA117th CongressS-2416| Senate
| Updated: 7/21/2021
Richard Burr
Republican Senator
North Carolina
Finance Committee
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
New Opportunities for Value that Extend Lives Act of 2021 or the NOVEL Act of 2021 This bill establishes a process for expediting the assignment of Healthcare Common Procedure Coding System (HCPCS) codes to medical products that have been designated as a breakthrough product or regenerative advanced therapy by the Food and Drug Administration; it also establishes a process for determining coverage under Medicare of such breakthrough products that have been assigned HCPCS codes.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Finance.
Health
Drug safety, medical device, and laboratory regulationDrug therapyGovernment information and archivesHealth care costs and insuranceHealth care coverage and accessHealth technology, devices, suppliesManufacturingMedicarePublic participation and lobbying
NOVEL Act of 2021
USA117th CongressS-2416| Senate
| Updated: 7/21/2021
New Opportunities for Value that Extend Lives Act of 2021 or the NOVEL Act of 2021 This bill establishes a process for expediting the assignment of Healthcare Common Procedure Coding System (HCPCS) codes to medical products that have been designated as a breakthrough product or regenerative advanced therapy by the Food and Drug Administration; it also establishes a process for determining coverage under Medicare of such breakthrough products that have been assigned HCPCS codes.
View Full TextSuggested Questions
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Read twice and referred to the Committee on Finance.
Richard Burr
Republican Senator
North Carolina
Finance Committee
Health
- Introduced
- In Committee
- On Floor
- Passed Chamber
- Enacted
Drug safety, medical device, and laboratory regulationDrug therapyGovernment information and archivesHealth care costs and insuranceHealth care coverage and accessHealth technology, devices, suppliesManufacturingMedicarePublic participation and lobbying